Processa Pharmaceuticals Stock Probability of Future Stock Price Finishing Over 2.22
| PCSA Stock | USD 2.22 0.07 3.06% |
Processa Pharmaceuticals Target Price Odds to finish over 2.22
The tendency of Processa Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 2.22 | 90 days | 2.22 | about 88.12 |
Based on a normal probability distribution, the odds of Processa Pharmaceuticals to move above the current price in 90 days from now is about 88.12 (This Processa Pharmaceuticals probability density function shows the probability of Processa Stock to fall within a particular range of prices over 90 days) .
Processa Pharmaceuticals Price Density |
| Price |
Predictive Modules for Processa Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Processa Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Processa Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Processa Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Processa Pharmaceuticals is not an exception. The market had few large corrections towards the Processa Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Processa Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Processa Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.77 | |
β | Beta against Dow Jones | -0.18 | |
σ | Overall volatility | 1.99 | |
Ir | Information ratio | -0.05 |
Processa Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Processa Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Processa Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Processa Pharmaceuticals generated a negative expected return over the last 90 days | |
| Processa Pharmaceuticals has high historical volatility and very poor performance | |
| Processa Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (11.85 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Processa Pharmaceuticals currently holds about 12.06 M in cash with (11.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.76. | |
| Processa Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Alliance Entertainment and Processa Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV - Erie Times-News |
Processa Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Processa Stock often depends not only on the future outlook of the current and potential Processa Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Processa Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 122.4 K | |
| Cash And Short Term Investments | 1.2 M |
Processa Pharmaceuticals Technical Analysis
Processa Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Processa Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Processa Pharmaceuticals. In general, you should focus on analyzing Processa Stock price patterns and their correlations with different microeconomic environments and drivers.
Processa Pharmaceuticals Predictive Forecast Models
Processa Pharmaceuticals' time-series forecasting models is one of many Processa Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Processa Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Processa Pharmaceuticals
Checking the ongoing alerts about Processa Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Processa Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Processa Pharmaceuticals generated a negative expected return over the last 90 days | |
| Processa Pharmaceuticals has high historical volatility and very poor performance | |
| Processa Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (11.85 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Processa Pharmaceuticals currently holds about 12.06 M in cash with (11.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.76. | |
| Processa Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Alliance Entertainment and Processa Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV - Erie Times-News |
Check out Processa Pharmaceuticals Analysis, Processa Pharmaceuticals Valuation, Processa Pharmaceuticals Correlation, Processa Pharmaceuticals Hype Analysis, Processa Pharmaceuticals Volatility, Processa Pharmaceuticals Price History as well as Processa Pharmaceuticals Performance. For information on how to trade Processa Stock refer to our How to Trade Processa Stock guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Processa Pharmaceuticals. Anticipated expansion of Processa directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Processa Pharmaceuticals assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate Processa Pharmaceuticals using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Processa Pharmaceuticals' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Processa Pharmaceuticals' market price to deviate significantly from intrinsic value.
It's important to distinguish between Processa Pharmaceuticals' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Processa Pharmaceuticals should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Processa Pharmaceuticals' market price signifies the transaction level at which participants voluntarily complete trades.